AstraZeneca PLC Ordinary Shares (AZN)

Dividends Paid

-$4.88B

TTM · Period ending: · USD

AZN logo

AZN Dividends Paid

Latest reported-$4.88B
AZN TTM Dividends Paid (-$1.61M → -$4.88B)
High-resolution chart · PNG

AZN dividends paid history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Dividends Paid — Trailing twelve months (TTM) (USD)
Period endingDividends Paid (USD)
-4,883,559,508
-4,887,223,745
-4,947,223,745
-4,962,591,653
-4,936,000,000
-4,943,000,000
-4,629,000,000
-4,628,000,000
-4,462,000,000
-4,467,000,000
-4,481,000,000
-4,581,716,296
-4,564,716,296
-4,631,866,548
-4,555,866,548
-4,467,669,543
-4,461,669,543
-4,356,241,284
-3,854,241,284
-3,811,893,088
-3,598,893,088
-3,615,171,095
-3,544,171,095
-3,572,000,000
-3,558,000,000
-3,558,000,000
-3,592,000,000
-3,592,000,000
-3,553,000,000
-3,553,000,000
-3,484,000,000
-3,484,000,000
-3,514,000,000
-3,514,000,000
-3,519,000,000
-3,519,000,000
-3,520,000,000
-3,520,000,000
-3,561,000,000
-3,561,000,000
-3,538,000,000
-3,538,000,000
-3,486,000,000
-3,486,000,000
-3,453,000,000
-3,453,000,000
-3,521,000,000
-3,521,000,000
-3,590,000,000
-3,590,000,000
-3,461,000,000
-3,461,000,000
-3,456,000,000
-3,456,000,000
-3,665,000,000
-3,667,000,000
-3,625,000,000
-3,663,000,000
-3,804,000,000
-3,802,000,000
-3,678,000,000
-3,640,000,000
-3,361,000,000
-3,361,000,000
-3,241,000,000
-3,241,000,000
-2,977,000,000
-2,977,000,000
-2,835,000,000
-2,835,000,000
-2,739,000,000
-2,739,000,000
-2,770,000,000
-2,770,000,000
-2,641,000,000
-2,641,000,000
-2,656,000,000
-2,656,000,000
-2,220,000,000
-2,220,000,000
-2,080,000,000
-2,080,000,000
-1,717,000,000
-1,717,000,000
-1,560,000,000
-1,560,000,000
-481,000,000
-933,000,000
-454,146,368
-454,146,368
-454,146,368
-417,948,248
-422,278,536
-422,278,536
-422,278,536
-6,476,656
-4,432,580
-4,432,580
-4,432,580
-4,432,580
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.